ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study

Deesje Doppenberg; Thomas F. Stoop; Susan van Dieren; Matthew H. G. Katz; Quisette P. Janssen; Naaz Nasar; Laura R. Prakash; Rutger T. Theijse; Ching-Wei D. Tzeng; Alice C. Wei; Amer H. Zureikat; Bas Groot Koerkamp; Marc G. Besselink

doi:10.1245/s10434-023-14752-1

ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study

Deesje Doppenberg, Thomas F. Stoop, Susan van Dieren, Matthew H. G. Katz, Quisette P. Janssen, Naaz Nasar, Laura R. Prakash, Rutger T. Theijse, Ching-Wei D. Tzeng, Alice C. Wei, Amer H. Zureikat, Bas Groot Koerkamp, Marc G. Besselink

Surgery

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	1954-1955
Number of pages	2
Journal	Annals of Surgical Oncology
Volume	31
Issue number	3
Early online date	15 Dec 2023
DOIs	https://doi.org/10.1245/s10434-023-14752-1
Publication status	Published - 1 Mar 2024

Access to Document

10.1245/s10434-023-14752-1

Cite this

Doppenberg, D., Stoop, T. F., van Dieren, S., Katz, M. H. G., Janssen, Q. P., Nasar, N., Prakash, L. R., Theijse, R. T., Tzeng, C.-W. D., Wei, A. C., Zureikat, A. H., Groot Koerkamp, B., & Besselink, M. G. (2024). ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study. Annals of Surgical Oncology, 31(3), 1954-1955. https://doi.org/10.1245/s10434-023-14752-1

@article{54280d811d9b477cabb74ea3123af9e3,

title = "ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study",

author = "Deesje Doppenberg and Stoop, {Thomas F.} and {van Dieren}, Susan and Katz, {Matthew H. G.} and Janssen, {Quisette P.} and Naaz Nasar and Prakash, {Laura R.} and Theijse, {Rutger T.} and Tzeng, {Ching-Wei D.} and Wei, {Alice C.} and Zureikat, {Amer H.} and {Groot Koerkamp}, Bas and Besselink, {Marc G.}",

year = "2024",

month = mar,

day = "1",

doi = "10.1245/s10434-023-14752-1",

language = "English",

volume = "31",

pages = "1954--1955",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer New York",

number = "3",

}

Doppenberg, D, Stoop, TF, van Dieren, S, Katz, MHG, Janssen, QP, Nasar, N, Prakash, LR, Theijse, RT, Tzeng, C-WD, Wei, AC, Zureikat, AH, Groot Koerkamp, B & Besselink, MG 2024, 'ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study', Annals of Surgical Oncology, vol. 31, no. 3, pp. 1954-1955. https://doi.org/10.1245/s10434-023-14752-1

ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study. / Doppenberg, Deesje; Stoop, Thomas F.; van Dieren, Susan et al.
In: Annals of Surgical Oncology, Vol. 31, No. 3, 01.03.2024, p. 1954-1955.

Research output: Contribution to journal › Editorial › Academic › peer-review

TY - JOUR

T1 - ASO Visual Abstract

T2 - Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study

AU - Doppenberg, Deesje

AU - Stoop, Thomas F.

AU - van Dieren, Susan

AU - Katz, Matthew H. G.

AU - Janssen, Quisette P.

AU - Nasar, Naaz

AU - Prakash, Laura R.

AU - Theijse, Rutger T.

AU - Tzeng, Ching-Wei D.

AU - Wei, Alice C.

AU - Zureikat, Amer H.

AU - Groot Koerkamp, Bas

AU - Besselink, Marc G.

PY - 2024/3/1

Y1 - 2024/3/1

UR - http://www.scopus.com/inward/record.url?scp=85184516721&partnerID=8YFLogxK

U2 - 10.1245/s10434-023-14752-1

DO - 10.1245/s10434-023-14752-1

M3 - Editorial

C2 - 38102327

SN - 1068-9265

VL - 31

SP - 1954

EP - 1955

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

IS - 3

ER -

Doppenberg D, Stoop TF, van Dieren S, Katz MHG, Janssen QP, Nasar N et al. ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study. Annals of Surgical Oncology. 2024 Mar 1;31(3):1954-1955. Epub 2023 Dec 15. doi: 10.1245/s10434-023-14752-1

ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study

Access to Document

Other files and links

Cite this